Literature DB >> 19556088

Non-contrast-enhanced hepatic MR angiography: do two-dimensional parallel imaging and short tau inversion recovery methods shorten acquisition time without image quality deterioration?

Kotaro Shimada1, Hiroyoshi Isoda, Tomohisa Okada, Toshikazu Kamae, Shigeki Arizono, Yuusuke Hirokawa, Toshiya Shibata, Kaori Togashi.   

Abstract

OBJECTIVE: To study whether shortening the acquisition time for selective hepatic artery visualization is feasible without image quality deterioration by adopting two-dimensional (2D) parallel imaging (PI) and short tau inversion recovery (STIR) methods.
MATERIALS AND METHODS: Twenty-four healthy volunteers were enrolled. 3D true steady-state free-precession imaging with a time spatial labeling inversion pulse was conducted using 1D or 2D-PI and fat suppression by chemical shift selective (CHESS) or STIR methods. Three groups of different scan conditions were assigned and compared: group A (1D-PI factor 2 and CHESS), group B (2D-PI factor 2×2 and CHESS), and group C (2D-PI factor 2×2 and STIR). The artery-to-liver contrast was quantified, and the quality of artery visualization and overall image quality were scored.
RESULTS: The mean scan time was 9.5±1.0 min (mean±standard deviation), 5.9±0.8 min, and 5.8±0.5 min in groups A, B, and C, respectively, and was significantly shorter in groups B and C than in group A (P<0.01). The artery-to-liver contrast was significantly better in group C than in groups A and B (P<0.01). The scores for artery visualization and overall image quality were worse in group B than in groups A and C. The differences were statistically significant (P<0.05) regarding the arterial branches of segments 4 and 8. Between group A and group C, which had similar scores, there were no statistically significant differences.
CONCLUSION: Shortening the acquisition time for selective hepatic artery visualization was feasible without deterioration of the image quality by the combination of 2D-PI and STIR methods. It will facilitate using non-contrast-enhanced MRA in clinical practice.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556088     DOI: 10.1016/j.ejrad.2009.05.051

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

1.  Diagnostic accuracy of magnetic resonance angiography for Budd-Chiari syndrome: A meta-analysis.

Authors:  Peng Xu; Lulu Lyu; Muhammad Umair Sami; Xin Lu; Haitao Ge; Yutao Rong; Chunfeng Hu; Kai Xu
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

2.  Non-Contrast-Enhanced and Contrast-Enhanced Magnetic Resonance Angiography in Living Donor Liver Vascular Anatomy.

Authors:  Chien-Chang Liao; Meng-Hsiang Chen; Chun-Yen Yu; Leung-Chit Leo Tsang; Chao-Long Chen; Hsien-Wen Hsu; Wei-Xiong Lim; Yi-Hsuan Chuang; Po-Hsun Huang; Yu-Fan Cheng; Hsin-You Ou
Journal:  Diagnostics (Basel)       Date:  2022-02-15

3.  Hemodynamic study of unenhanced magnetic resonance angiography using spatial labeling with multiple inversion pulses sequence: a phantom study.

Authors:  Xiao Chen; Xiaoyan Meng; Di Zhu; Xianlun Zou; Yaqi Shen; Zhen Li; Jian Peng; Daoyu Hu
Journal:  Quant Imaging Med Surg       Date:  2021-05

4.  Magnetic Resonance Venography Findings of Obstructed Hepatic Veins and the Inferior Vena Cava in Patients with Budd-Chiari Syndrome.

Authors:  Ru-Xin Song; Shi-Feng Cai; Shuang Ma; Zhi-Ling Liu; Yong-Hao Gai; Chun-Qing Zhang; Guang-Chuan Wang
Journal:  Korean J Radiol       Date:  2018-04-06       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.